CHRISTOPHER JARVIS: Open Payments
NPI 1508860479 · BURLINGTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 37 payments from 14 companies in 2025. Trend: 2023 $841 · 2024 $795 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $107 |
| ABBVIE INC. | 4 | $81 |
| Axsome Therapeutics, Inc. | 5 | $76 |
| Verona Pharma, Inc. | 4 | $75 |
| Novo Nordisk Inc | 4 | $70 |
| Viatris Specialty LLC | 3 | $63 |
| Dexcom, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| PFIZER INC. | 1 | $23 |
Products named: REXULTI, Auvelity, Ohtuvayre, YUPELRI, UBRELVY, Ozempic, QULIPTA, DEXCOM G7 GSS (161).
Industry payments across KS — which companies pay providers there.
